Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05480839
Other study ID # UptownEye2
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 1, 2022
Est. completion date August 31, 2022

Study information

Verified date July 2022
Source Uptown Eye Specialists
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The focus of this study is to assess the differences in patient perceptions of pain undergoing cataract surgery by using the Refractive Laser-Assisted Cataract Surgery (ReLACS) technique compared to the standard Manual Cataract Surgery (MCS) technique using an immediately sequential bilateral approach. This study also aims to further explore difference in patients' perceptions of pain depending on timing of neurolept anesthesia in the ReLACS technique. The importance of this study is appreciated patient perception of pain during ReLACS, which is an emerging technique for cataract surgery and has been sparsely reported on to date. This investigation will include the analysis of various surgical, ocular, medical, and psychosocial metrics of patients undergoing both ReLACS and MCS at Uptown Eye specialist.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date August 31, 2022
Est. primary completion date August 31, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Patients undergoing uncomplicated cataract surgery with either surgical technique (M-ISBCS or ReLA-ISBCS) - Patients who require surgery in both eyes by the same surgeon - Able to understand English and complete a pain assessment (NRS) Exclusion Criteria: - Deafness or communication disorder, known Dementia, Severe COPD/Asthma (severe lung disorder), Severe OSA, Psychiatric or Anxiety conditions, involuntary movement disorders, allergy to the anesthesia, any conditions requiring intraoperative iris manipulation, any prior ocular surgery - Pre-existing chronic eye pain or uveitis, or complicated cataracts (dislocation, zonulopathy) - Pre-existing uncontrolled glaucoma/high IOP - Intraoperative complications or non-routine cataracts (eg. Sutures, excessive time of surgery) - Any patient who requires Deep Sedation (Propofol), GA or preOP Ativan - Patients under 40, severe obesity (BMI >35) - Chronic pain/narcotics/recreational or medical marijuana

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
M-IBCS
Manual Cataract Surgery - Phacoemulsification: removal of the eye lens and insertion of an intraocular lens implant
ReLA-IBCS Early
Refractive Laser-Assisted Immediately Sequential Bilateral Cataract Surgery - ReLA-IBSCS with early administration of anesthesia
ReLA-ISBCS
Refractive Laser-Assisted Immediately Sequential Bilateral Cataract Surgery - ReLA-IBSCS with standard administration of anesthesia

Locations

Country Name City State
Canada Uptown Eye Specialist Brampton Ontario

Sponsors (1)

Lead Sponsor Collaborator
Uptown Eye Specialists

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain Perception between Manual Immediately Sequential Bilateral Cataract Surgery (M-ISBCS) and Refractive Laser-Assisted Immediately Sequential Cataract Surgery (ReLA-ISCS) Pain perceptions of patients undergoing M-IBCS vs ReLA-ISBCS will be measured using the Numerical Rating Scale (NRS) with pain ratings from 0 to 10. 1 year
Secondary Effects of Early vs Standard administration of topical neurolept anesthesia on pain perception Pain perceptions of patients undergoing ReLA-ISBCS Early vs ReLA-ISBCS Standard will be measured using the Numerical Rating Scale (NRS) with pain ratings from 0 to 10. 1 Year
See also
  Status Clinical Trial Phase
Completed NCT04623229 - A Comparison of Patient Perceptions Undergoing Manual Cataract Surgery (MCS) vs Refractive Laser-assisted Cataract Surgery (ReLACS) in First and Second Eyes N/A